Kirsten Boonstra

3.0k citations

20 papers · 1.7k indexed · 2 hit papers · h-index 13

Hepatology top 0.5%
Epidemiology top 2%
Surgery top 5%
Pulmonary and Respiratory Medicine top 5%
Genetics top 10%

Co-authors: Cyriel Y. Ponsioen Ulrich Beuers Hans A.R.E. Tuynman Alexander C. Poen Ben Witteman Karel J. van Erpecum Joost P.H. Drenth Rinse K. Weersma
Topics: Liver Diseases and Immunity (12 papers)Liver Disease Diagnosis and Treatment (11 papers)Gallbladder and Bile Duct Disorders (6 papers)
Cited by: Hepatology Epidemiology Surgery
Journals: Gastroenterology Hepatology Gut
Partner nations: Netherlands United Kingdom Canada

In The Last Decade

Kirsten Boonstra

20 papers receiving 1.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Population-based epidemiology, malignancy risk, and outcome of primary sclerosing cholangitis

2013 472 citations Kirsten Boonstra, Rinse K. Weersma et al. Hepatology profile →
Epidemiology of primary sclerosing cholangitis and primary biliary cirrhosis: A systematic review

2012 424 citations Kirsten Boonstra, Ulrich Beuers et al. Journal of Hepatology profile →

Peers

Countries citing papers authored by Kirsten Boonstra

Since Specialization

Citations

This map shows the geographic impact of Kirsten Boonstra's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kirsten Boonstra with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kirsten Boonstra more than expected).

Fields of papers citing papers by Kirsten Boonstra

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kirsten Boonstra. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kirsten Boonstra. The network helps show where Kirsten Boonstra may publish in the future.

Co-authorship network of co-authors of Kirsten Boonstra

This figure shows the co-authorship network connecting the top 25 collaborators of Kirsten Boonstra. A scholar is included among the top collaborators of Kirsten Boonstra based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kirsten Boonstra. Kirsten Boonstra is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Endoscopic vacuum therapy in the upper gastrointestinal tract 2025 ·PubMed ·Kirsten Boonstra,(unknown),Yasmijn van Herwaarden,Wietse J. Eshuis,Roos E. Pouw	1
2	Management of iatrogenic perforations during endoscopic interventions in the hepato-pancreatico-biliary tract 2024 ·Best Practice & Research Clinical Gastroenterology ·Kirsten Boonstra,Rogier P. Voermans,Roy L.J. van Wanrooij	1
3	Disease burden in primary sclerosing cholangitis in the Netherlands: A long‐term follow‐up study 2022 ·Liver International ·(unknown),Bregje Mol,Jorn Goet,Sanne N. van Munster,Rinse K. Weersma,Annemarie C. de Vries,Rozanne C. de Veer,Akin Inderson,Joost P.H. Drenth,Karel J. van Erpecum,Kirsten Boonstra,Ulrich Beuers,Marcel G. W. Dijkgraaf,Cyriel Y. Ponsioen,(unknown)	11
4	A novel prognostic model for transplant-free survival in primary sclerosing cholangitis 2017 ·Gut ·(unknown),Junfeng Wang,Kate D. Williamson,Mariska Leeflang,Kirsten Boonstra,Rinse K. Weersma,Ulrich Beuers,Roger W. Chapman,Ronald B. Geskus,Cyriel Y. Ponsioen	84
5	Burden of disease and increasing prevalence of inflammatory bowel disease in a population-based cohort in the Netherlands 2016 ·European Journal of Gastroenterology & Hepatology ·E. Joline de Groof,Noortje Rossen,Bram D. van Rhijn,(unknown),Kirsten Boonstra,(unknown),Floor Bennebroek Evertsz,Paul J. Kingma,A.H.J. Naber,(unknown),Rosalie C. Mallant–Hent,Marco W. Mundt,Geert D’Haens,Cyriel Y. Ponsioen	46
6	Alkaline phosphatase at diagnosis of primary sclerosing cholangitis and 1 year later: evaluation of prognostic value 2016 ·Liver International ·Elisabeth M. G. de Vries,Junfeng Wang,Mariska Leeflang,Kirsten Boonstra,Rinse K. Weersma,Ulrich Beuers,Ronald B. Geskus,Cyriel Y. Ponsioen	61
7	Applicability and prognostic value of histologic scoring systems in primary sclerosing cholangitis 2015 ·Journal of Hepatology ·Elisabeth M. G. de Vries,Joanne Verheij,Stefan G. Hübscher,Mariska Leeflang,Kirsten Boonstra,Ulrich Beuers,Cyriel Y. Ponsioen	47
8	IgG4-Associated Cholangitis - A Mimic of PSC 2015 ·Digestive Diseases ·Ulrich Beuers,Lowiek M. Hubers,Marieke E. Doorenspleet,(unknown),Paul L. Klarenbeek,Kirsten Boonstra,Cyriel Y. Ponsioen,Erik A. Rauws,Niek de Vries	12
9	Su1313 Epidemiology and Characteristics of Inflammatory Bowel Disease in a Large Population-Based Cohort in the Netherlands 2015 ·Gastroenterology ·E. Joline de Groof,Noortje Rossen,Bram D. van Rhijn,(unknown),Kirsten Boonstra,(unknown),Paul J. Kingma,A.H.J. Naber,(unknown),Rosalie C. Mallant–Hent,Marco W. Mundt,Geert D’Haens,Cyriel Y. Ponsioen	1
10	Risk factors for primary sclerosing cholangitis 2015 ·Liver International ·Kirsten Boonstra,Elisabeth M. G. de Vries,Nan van Geloven,Karel J. van Erpecum,Marcel Spanier,Alexander C. Poen,(unknown),Ben Witteman,Hans A.R.E. Tuynman,A.H.J. Naber,Paul J. Kingma,Ulrich Beuers,Cyriel Y. Ponsioen,(unknown)	20
11	Increased cancer risk in a large population-based cohort of patients with primary biliary cirrhosis: follow-up for up to 36 years 2014 ·Hepatology International ·Kirsten Boonstra,(unknown),P.H.G.M. Stadhouders,Hans A.R.E. Tuynman,Alexander C. Poen,(unknown),Ellen M. Witteman,Dörte Hamann,Ben Witteman,Ulrich Beuers,Cyriel Y. Ponsioen	27
12	The Mucosa-associated Microbiota of PSC Patients is Characterized by Low Diversity and Low Abundance of Uncultured Clostridiales II 2014 ·Journal of Crohn s and Colitis ·Noortje Rossen,Susana Fuentes,Kirsten Boonstra,Geert D’Haens,Hans G. H. J. Heilig,Erwin G. Zoetendal,Willem M. de Vos,Cyriel Y. Ponsioen	89
13	305 Normalization of Alkaline Phosphatase Within the First Year After Diagnosis Is of Prognostic Value in Primary Sclerosing Cholangitis 2014 ·Gastroenterology ·(unknown),Mariska Leeflang,Kirsten Boonstra,Ulrich Beuers,(unknown)	1
14	Rising incidence and prevalence of primary biliary cirrhosis: a large population‐based study 2014 ·Liver International ·Kirsten Boonstra,Anton E. Kunst,P.H.G.M. Stadhouders,Hans A.R.E. Tuynman,Alexander C. Poen,Karin M.J. van Nieuwkerk,Ellen M. Witteman,Dörte Hamann,Ben Witteman,Ulrich Beuers,Cyriel Y. Ponsioen,(unknown)	77
15	922 INCREASED CANCER RISK IN A LARGE POPULATION-BASED COHORT OF PATIENTS WITH PRIMARY BILIARY CIRRHOSIS: FOLLOW-UP FOR UP TO 36 YEARS 2013 ·Journal of Hepatology ·Kirsten Boonstra,P.H.G.M. Stadhouders,Hans A.R.E. Tuynman,Alexander C. Poen,Carin M.J. van Nieuwkerk,Ellen M. Witteman,Dörte Hamann,Ben Witteman,Ulrich Beuers,Cyriel Y. Ponsioen	4
16	Serum Immunoglobulin G4 and Immunoglobulin G1 for Distinguishing Immunoglobulin G4-Associated Cholangitis From Primary Sclerosing Cholangitis 2013 ·Hepatology ·Kirsten Boonstra,Emma Culver,Lucas J. Maillette de Buy Wenniger,Marianne J. Van Heerde,Karel J. van Erpecum,Alexander C. Poen,Karin M.J. van Nieuwkerk,Marcel Spanier,Ben Witteman,Hans A.R.E. Tuynman,Nan van Geloven,Henk van Buuren,Roger W. Chapman,Eleanor Barnes,Ulrich Beuers,Cyriel Y. Ponsioen	125
17	Population-based epidemiology, malignancy risk, and outcome of primary sclerosing cholangitisbreakdown → 2013 ·Hepatology ·Kirsten Boonstra,Rinse K. Weersma,Karel J. van Erpecum,Erik A. Rauws,B.W.M. Spanier,Alexander C. Poen,(unknown),Joost P.H. Drenth,Ben Witteman,Hans A.R.E. Tuynman,A.H.J. Naber,Paul J. Kingma,Henk R. van Buuren,Bart van Hoek,Frank P. Vleggaar,Nan van Geloven,Ulrich Beuers,Cyriel Y. Ponsioen,(unknown)	472
18	Epidemiology of primary sclerosing cholangitis and primary biliary cirrhosis: A systematic reviewbreakdown → 2012 ·Journal of Hepatology ·Kirsten Boonstra,Ulrich Beuers,Cyriel Y. Ponsioen	424
19	Primary sclerosing cholangitis is associated with a distinct phenotype of inflammatory bowel disease 2012 ·Inflammatory Bowel Diseases ·Kirsten Boonstra,Karel J. van Erpecum,Karin M.J. van Nieuwkerk,Joost P.H. Drenth,Alexander C. Poen,Ben Witteman,Hans A.R.E. Tuynman,Ulrich Beuers,Cyriel Y. Ponsioen	153
20	Tu1286 Epidemiology and Characteristics of Inflammatory Bowel Disease in a Large Population-Based Cohort in Central Netherlands 2012 ·Gastroenterology ·Noortje Rossen,Bram D. van Rhijn,(unknown),Kirsten Boonstra,Paul J. Kingma,A.H.J. Naber,(unknown),Cyriel Y. Ponsioen	1

About Kirsten Boonstra

Kirsten Boonstra is a scholar working on Hepatology, Epidemiology and Pulmonary and Respiratory Medicine, having authored 20 papers that have together received 1.7k indexed citations. Recurring topics across this work include Liver Diseases and Immunity (12 papers), Liver Disease Diagnosis and Treatment (11 papers) and Gallbladder and Bile Duct Disorders (6 papers). The work is most often cited by research in Hepatology (1.3k citations), Epidemiology (993 citations) and Surgery (923 citations). Kirsten Boonstra has collaborated with scholars based in Netherlands, United Kingdom and Canada. Frequent co-authors include Cyriel Y. Ponsioen, Ulrich Beuers, Hans A.R.E. Tuynman, Alexander C. Poen, Ben Witteman, Karel J. van Erpecum, Joost P.H. Drenth, Rinse K. Weersma, Nan van Geloven and Karin M.J. van Nieuwkerk. Their work appears in journals such as Gastroenterology, Hepatology and Gut.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact